Kraig Biocraft Laboratories Signs Landmark Collaborative Agreement with Government Agency in Southeast Asia to Advance Spider Silk Production
Rhea-AI Summary
Kraig Biocraft Laboratories (OTCQB: KBLB), a biotechnology company specializing in spider silk technology, has signed a significant multi-year agreement with a Southeast Asian government agency to advance its spider silk production capabilities.
The collaboration provides Kraig Labs with access to government-supported rearing facilities, technical personnel, and infrastructure essential for scaling up production and expanding operational capacity. The company plans to initiate operations at the new facility in early August 2025.
This strategic partnership represents the culmination of years of groundwork and positions the company to accelerate its path toward large-scale commercialization of next-generation biomaterials.
Positive
- Access to government-supported rearing facilities and infrastructure
- Technical personnel support from government agency
- Accelerated path to large-scale commercialization
- Immediate timeline for facility operations (August 2025)
Negative
- No specific financial terms or economic impact disclosed
- Exact location and partner agency in Southeast Asia not specified
News Market Reaction – KBLB
In the trading session that priced this news, KBLB gained 0.12%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANN ARBOR, Mich., July 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the formal signing of a multi-year agreement with a government agency in Southeast Asia to support the scale-up of its recombinant spider silk production.
This agreement is the result of many years of groundwork by Kraig Labs and marks a significant step in the Company's ongoing efforts to commercialize next-generation biomaterials. Under the terms of the agreement, Kraig Labs will gain access to government-supported rearing facilities, technical personnel, and infrastructure critical to accelerating production and expanding operational capacity.
"This milestone reflects many years of work by our senior management and on-the-ground team," said COO of Kraig Labs, Jon Rice. "With the support of this agreement, we are now positioned to move more quickly and efficiently toward large-scale commercialization."
Kraig Labs expects to take possession of the new facility and initiate operations in early August.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
ir@KraigLabs.com
